Benzinga - by Benzinga Insights, Benzinga Staff Writer.
A significant insider transaction involving the exercise of company stock options was reported on December 7, by Stephen J Hemsley, Director at UnitedHealth Group (NYSE:UNH), as per the latest SEC filing.
What Happened: Hemsley, Director at UnitedHealth Group, exercised stock options for 66,081 shares of UNH stock. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday. The exercise price of the options was $108.97 per share.
During Friday's morning session, UnitedHealth Group shares down by 0.05%, currently priced at $548.0. Considering the current price, Hemsley's 66,081 shares have a total value of $29,011,541.
About UnitedHealth Group UnitedHealth Group is one of the largest private health insurers, providing medical benefits to about 53 million members globally, including 5 million outside the U.S. as of mid-2023. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Financial Insights: UnitedHealth Group Revenue Growth: Over the 3 months period, UnitedHealth Group showcased positive performance, achieving a revenue growth rate of 14.18% as of 30 September, 2023. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Key Profitability Indicators:
- Gross Margin: With a low gross margin of 25.32%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
- Earnings per Share (EPS): UnitedHealth Group's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 6.31.
Valuation Analysis:
- Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 23.8, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
- Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 1.43, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
- EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): UnitedHealth Group's EV/EBITDA ratio, lower than industry averages at 14.81, indicates attractively priced shares.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Understanding the Significance of Insider Transactions While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.
Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.
Cracking Transaction Codes For investors, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
Check Out The Full List Of UnitedHealth Group's Insider Trades.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.